Tailoring Adverse Event Prediction in Type 1 Diabetes with Patient-Specific Deep Learning Models

2026-01-21

AI Summary

This study addresses the challenge of inaccurate prediction of hypoglycemic and hyperglycemic events in individuals with type 1 diabetes by proposing a patient-specific deep learning approach for personalized glucose forecasting. The method integrates continuous glucose monitoring (CGM) data with multimodal physiological signals and employs a leave-one-subject-out cross-validation framework combined with fine-tuning to develop individualized models. The research systematically evaluates the minimum effective training data requirement and quantifies the performance gains attributable to multimodal data integration. Experimental results demonstrate that the proposed approach significantly outperforms both generic models and CGM-only baselines, achieving substantial improvements in prediction accuracy and response speed. These advances offer strong support for personalized insulin intervention strategies and the development of closed-loop insulin delivery systems.

Technology Category

• Machine Learning: Multimodal Learning
• Cognitive Modeling & Cognitive Systems: Neural Spike Coding
• Natural Language Processing: Language Grounding & Multi-modal NLP

Application Category

• User Modeling, Personalization and Recommendation: On-Device user modeling, personalization, and recommendation
• Graph Algorithms and Modeling for the Web: Graph neural networks and deep learning approaches for Web-related graphs
• Semantics and Knowledge: Methods to enhance, augment, integrate or synergize semantic models such as knowledge graphs and LLMs

Abstract

Effective management of Type 1 Diabetes requires continuous glucose monitoring and precise insulin adjustments to prevent hyperglycemia and hypoglycemia. With the growing adoption of wearable glucose monitors and mobile health applications, accurate blood glucose prediction is essential for enhancing automated insulin delivery and decision-support systems. This paper presents a deep learning-based approach for personalized blood glucose prediction, leveraging patient-specific data to improve prediction accuracy and responsiveness in real-world scenarios. Unlike traditional generalized models, our method accounts for individual variability, enabling more effective subject-specific predictions. We compare Leave-One-Subject-Out Cross-Validation with a fine-tuning strategy to evaluate their ability to model patient-specific dynamics. Results show that personalized models significantly improve the prediction of adverse events, enabling more precise and timely interventions in real-world scenarios. To assess the impact of patient-specific data, we conduct experiments comparing a multimodal, patient-specific approach against traditional CGM-only methods. Additionally, we perform an ablation study to investigate model performance with progressively smaller training sets, identifying the minimum data required for effective personalization-an essential consideration for real-world applications where extensive data collection is often challenging. Our findings underscore the potential of adaptive, personalized glucose prediction models for advancing next-generation diabetes management, particularly in wearable and mobile health platforms, enhancing consumer-oriented diabetes care solutions.

Problem

• Type 1 Diabetes
• Adverse Event Prediction
• Personalized Modeling
• Blood Glucose Prediction
• Patient-Specific

Innovation

• personalized deep learning
• blood glucose prediction
• patient-specific modeling
• adverse event prediction
• multimodal data